Suchergebnisse - "Corominas, Hèctor"

PubPharm (178)

1

Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort

enthalten in: RMD open | 2024

von Codes-Méndez, H. | Sainz, L. | Park, H. | +2

2

Incidence and clinical manifestations of giant cell arteritis in Spain : results of the ARTESER register

enthalten in: RMD open | 2024

von Fernández-Lozano, D. | Hernández-Rodríguez, I. | Narvaez, J. | +105

3

Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice

enthalten in: Lupus | 2024

von Frade-Sosa, B. | Salman-Monte, T. | Narváez, J. | +10

4

Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis

enthalten in: Medicina (Kaunas, Lithuania) | 2024

von Martinez-Molina, C. | Diaz-Torne, C. | Park, H. | +3

5

Utility of applying a diagnostic algorithm in giant cell arteritis based on the level of clinical suspicion

enthalten in: Medicina clinica | 2024

von Estrada, P. | Moya, P. | Narváez, J. | +8

6

Prognostic significance of lymphocytic foci composition in minor salivary gland biopsies for severe disease flare and severity in Sjögren's syndrome : a 3-year follow-up cohort study

enthalten in: Frontiers in immunology | 2024

von Park, H. | Martínez-Martínez, L. | Magallares López, B. | +13

7

Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis : a real-world study

enthalten in: Scientific reports | 2024

von Martinez-Molina, C. | Gich, I. | Diaz-Torné, C. | +4

8

Initial Treatment with Biological Therapy in Rheumatoid Arthritis

enthalten in: Journal of clinical medicine | 2023

von Tornero Molina, J. | Hernández-Cruz, B. | Corominas, H.

9

Altered CD39 and CD73 Expression in Rheumatoid Arthritis : Implications for Disease Activity and Treatment Response

enthalten in: Biomolecules | 2023

von Ortiz, M. | Diaz-Torné, C. | De Agustin, J. | +8

10

Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib

enthalten in: Clinical rheumatology | 2023

von Vallez-Valero, L. | Gasó-Gago, I. | Marcos-Fendian, �. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]